User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 1 - 25 of 71 results.

Pages

    • Journal article
    Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?
    Van den Eynde, Benoît[UCL] van Baren, Nicolas[UCL] Baurain, Jean-François[UCL] (2020) Annual review of cancer biology — Vol. 4, no. 1, p. 241-256 (2020)
    • Speech
    Neogenesis of lymphoid structures in metastatic melanoma.
    van Baren, Nicolas[UCL] (2012) NIBIT (Italian Network for Tumor Biotherapy) 10th Annual Meeting — Siena (Italy)
    • Speech
    Invited Lecture: Clinical and immunological effects in melanoma patients vaccinated with MAGE antigens.
    van Baren, Nicolas[UCL] (2006) The Second International Cancer Vaccine Meeting. — Borgo San Luigi, Monteriggioni (Siena, Italy)
    • Journal article
    New vaccination approaches in melanoma with tumor antigens recognized by T lymphocytes.
    Marchand, Marie[UCL] van Baren, Nicolas[UCL] Raimundo, A.[UCL] Humblet, Yves[UCL] Tromme, Isabelle[UCL] (2002) Nederlands Tijdschrift voor Dermatologie en Venerologie — Vol. 12, p. 344-345 (2002)
    • Journal article
    Peptide-based cancer vaccines
    Machiels, Jean-Pascal[UCL] van Baren, Nicolas[UCL] Marchand, Marie[UCL] (2002) Seminars in Oncology — Vol. 29, no. 5, p. 494-502 (2002)
    • Journal article
    Defining the prognostic value for galectin-3 in cutaneous melanoma.
    Vereecken, P Ghanem, G Morandini, R Suciu, S van Baren, Nicolas[UCL] Heenen, M (2007) The Journal of International Medical Research — Vol. 35, no. 5, p. 731-732 (2007)
    • BookChapter
    Improving the clinical efficacy of cancer vaccines by targeting immune suppression in human tumors
    Demotte, Nathalie[UCL] Antonopoulos, Aristotelis Baurain, Jean-François[UCL] Wieers, Grégoire[UCL] van Baren, Nicolas[UCL] van der Bruggen, Pierre[UCL] (2012) Galectins and Disease Implications for Targeted Therapeutics. Proceedings of the First Symposium on Galectin-Related Therapeutics — [ISBN : 978-0-8412-2880-1]
    • Speech
    Invited Lecture: Where do we go with peptides in cancer vaccines ?
    van Baren, Nicolas[UCL] Baurain, Jean-François[UCL] (2008) 2d meeting of the Cancerimmunotherapy Consortium — Brussels (Belgium)
    • Speech
    Monitoring CTL responses in cancer patients vaccinated with a tumor-specific antigen.
    van Baren, Nicolas[UCL] (2008) Meeting of the International Society for Cellular Therapy — Antwerp
    • Speech
    Immunotherapy of cancer. Where are we ?
    van Baren, Nicolas[UCL] (2009) 24th meeting of the Belgian Hematological Society — Oostende (Belgium)
    • Journal article
    Tryptophan-degrading enzymes in tumoral immune resistance
    van Baren, Nicolas[UCL] Van den Eynde, Benoît[UCL] (2015) Frontiers in Immunology — Vol. 6, no. 34, p. 1-9 (03/02/2015)
    • Journal article
    Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?
    Vereecken, Pierre Heenen, Michel Babar, Sajida van Baren, Nicolas[UCL] (2007) Journal of the European Academy of Dermatology and Venereology — Vol. 21, no. 2, p. 278-280 (2007)

Pages